Intellectual Property and Exploitation Sample Clauses

Intellectual Property and Exploitation. The copyright in the Artwork is and shall remain the property of the Artist as fixed in French Intellectual Property Law (Code de la propriété intellectuelle). The Artist certifies that he/she is the sole author of the Artwork, that this is an original work that does not copy other preexisting works. The Artist certifies that he/she has not already accepted nor will accept during the execution of the current contract any other agreement with a similar subject. The Artist grants all the other Extended Parties a non-exclusive right to publicly present the Artwork and its related public documentation through their dissemination channels. These rights-of-use are granted for the legal duration of the author’s rights or related rights or their rights holders, as governed by both French or foreign law, current or future, including possible extensions to this duration. These rights are applicable worldwide. The Artist certifies that he/she is the owner of the rights which he/she grants to the other Parties. The Artist guarantees to the Extended Parties the full use, clear of all claims, liens and encumbrances, of the rights granted in the current contract, and guarantees the Parties against any fraud, claim or eviction or counterfeit litigation. The ICT R&D Project Partner grants the other Extended Parties a non-exclusive right, applicable worldwide, to use the elements of the ICT R&D Project Technology necessary for the Residency execution, until the end of the current contract. It grants them a non-exclusive right applicable worldwide to use the elements of the ICT R&D Project Technology necessary for the operation of the Artwork at least three years after the end of the current contract. The ICT R&D Project Partner guarantees to the other Parties its full ownership of the rights necessary for these purposes. Any Extended Party presenting publicly the Artwork will take in charge without soliciting the other Parties the statements and the payment of author’s rights and performers’ rights fees to Royalties Collecting and Distributing Societies. The Parties grant any Extended Party rights to carry out, or cause to be carried out, shootings and/or audiovisual recordings during the work periods, of all staff involved in the Residency. The Parties authorize the concerned Extended Party to grant the right to reproduce, to use and to broadcast to the producer of the video recording. They authorize the concerned Extended Party, on free basis, non-exclusive and for an unl...
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Intellectual Property and Exploitation. 12.1. As a charity Wellbeing of Women is committed to improving the health of women and is obliged to ensure that results of research that it funds (whether in whole or in part) are applied for the public good. In some circumstances, this obligation may be best achieved through the protection of Intellectual Property and commercial exploitation.
Sample 1Sample 2Sample 3
Intellectual Property and Exploitation. 11.1 The Institution and the Grantholder acknowledge that Diabetes UK is under a duty to ensure that the Results (whether in whole or in part) are applied for the public benefit, and agree that this may require the protection and commercial exploitation of Grant Funded Intellectual Property.
Sample 1
Intellectual Property and Exploitation. The Institution and the Grantholder acknowledge that Diabetes UK is under a duty to ensure that the Results (whether in whole or in part) are applied for the public benefit, and that this may require the protection and exploitation of Grant Funded Intellectual Property. The Institution is responsible for taking all reasonable steps to identify and where relevant exploit any element of the Results that may be applied for public benefit. It is a condition of the Grant that, to the extent it does not already have appropriate procedures in place, the Institution develops and implements procedures for the identification, protection, management and exploitation of Grant Funded Intellectual Property. The Institution grants Diabetes UK a perpetual, irrevocable, worldwide, non-exclusive royalty free licence (with the right to sub-licence at Diabetes UK’s discretion) to use any Intellectual Property in the Results for non-commercial research, teaching and publicity purposes. Diabetes UK acknowledges that such licence is granted on the condition that Diabetes UK does not exploit the Grant Funded Intellectual Property for commercial purposes without the express prior written permission of the Institution. Diabetes UK acknowledges that the Institution and the Grantholder shall have the right to use any Grant Funded Intellectual Property created or arising from the Project for the purposes of non-commercial research and teaching, subject to the provisions set out in this Agreement. If the Institution identifies any Grant Funded Intellectual Property which it believes is capable of exploitation either for commercial purposes or for achieving public benefit, it will promptly notify Diabetes UK in writing. Following such notification, the Institution and Diabetes UK will co-operate in good faith to agree how best to exploit such Intellectual Property (in accordance with this clause 10). If Diabetes UK does not respond to the Institution’s written notification in relation to Grant Funded Intellectual Property within a period of 90 days from its receipt of such notice, the Institution (or its technology transfer company where appropriate) will have the right to proceed with commercial exploitation of the Grant Funded Intellectual Property without Diabetes UK’s consent, subject to its compliance as soon as it is reasonably able with clause 10.8. The Parties will use all reasonable endeavours to conclude a Revenue Sharing Agreement within 9 months of the Institution’s notifica...
Sample 1
Intellectual Property and Exploitation. 8.1. Background Intellectual Property used in connection with the Work shall remain the property of the Party introducing the same.
Sample 1
Intellectual Property and Exploitation. 11.1 The Institution and the Grantholder acknowledge that Diabetes UK and SMF are under a duty to ensure that the Results (whether in whole or in part) are applied for the public benefit, and agree that this may require the protection and commercial exploitation of Grant Funded Intellectual Property.
Sample 1

Related to Intellectual Property and Exploitation

  • INTELLECTUAL PROPERTY RIGHTS - DATA RIGHTS A. Data produced under this Annex which is subject to paragraph C. of the Intellectual Property Rights - Data Rights Article of the Umbrella Agreement will be protected for the period of one year.

  • Intellectual Property Rights Infringement HP will defend and/or settle any claims against Customer that allege that an HP-branded product or service as supplied under this Agreement infringes the intellectual property rights of a third party. HP will rely on Customer’s prompt notification of the claim and cooperation with our defense. HP may modify the product or service so as to be non-infringing and materially equivalent, or we may procure a license. If these options are not available, we will refund to Customer the amount paid for the affected product in the first year or the depreciated value thereafter or, for support services, the balance of any pre-paid amount or, for professional services, the amount paid. HP is not responsible for claims resulting from any unauthorized use of the products or services. This section shall also apply to deliverables identified as such in the relevant Support Material except that HP is not responsible for claims resulting from deliverables content or design provided by Customer.

  • Patents and Intellectual Property Rights Recipients are subject to the Xxxx-Xxxx Xxx, 00 U.S.C. § 200 et seq, unless otherwise provided by law. Recipients are subject to the specific requirements governing the development, reporting, and disposition of rights to inventions and patents resulting from federal financial assistance awards located at 37 C.F.R. Part 401 and the standard patent rights clause located at 37 C.F.R. § 401.14.

  • Intellectual Property Rights and Ownership 5.1. You acknowledge that all Intellectual Property Rights (including any new Intellectual Property Rights) arising out of or in connection with the Access Products and associated Documentation, belong at all times to Us or Our licensors.

  • INTELLECTUAL PROPERTY RIGHTS AND INDEMNITY 42.1 Save as granted under this Framework Agreement, neither the Authority nor the Supplier shall acquire any right, title or interest in the other's Pre-Existing Intellectual Property Rights.

  • Intellectual Property Rights The Company and each of its Subsidiaries owns or possesses or has valid rights to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights (“Intellectual Property Rights”) necessary for the conduct of the business of the Company and its Subsidiaries as currently carried on and as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. To the knowledge of the Company, no action or use by the Company or any of its Subsidiaries necessary for the conduct of its business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any Intellectual Property Rights of others. Neither the Company nor any of its Subsidiaries has received any written notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights owned by the Company and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; (D) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights of others, the Company has not received any written notice of such claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; and (E) to the Company’s knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee’s employment with the Company, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company’s knowledge, all material technical information developed by and belonging to the Company which has not been patented has been kept confidential. The Company is not a party to or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus and are not described therein. The Registration Statement, the Pricing Disclosure Package and the Prospectus contain in all material respects the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company’s knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any persons.

  • Intellectual Properties (a) All ownership, copyright, patent, trade secrecy and other rights in all works, designs, inventions, ideas, manuals, improvements, discoveries, processes, customer lists or other properties (the "Intellectual Properties") made or conceived by Executive during the term of his/her employment by the Company shall be the rights and property solely of the Company, whether developed independently by Executive or jointly with others, and whether or not developed or conceived during regular working hours or at the Company's facilities, and whether or not the Company uses, registers, or markets the same.

  • Third Party Intellectual Property Rights (a) In providing a Service, we may supply you with materials (including software) licensed by third parties.

  • Infringement of Intellectual Property Rights Seller (or its supplier) shall indemnify and hold Purchaser harmless against an award of damages and costs against Purchaser by a final judgment of a court of last resort in the country in which the Equipment is originally installed by Seller resulting from actual or alleged patent infringement relating in any way to use or sale of the Equipment, or any component thereof furnished hereunder, provided that Purchaser (i) gives Seller immediate notice in writing of any suit or claim for infringement against Purchaser, (ii) permits Seller (or its supplier) to control the defense of any suit or claim, and (iii) gives Seller (or its supplier) all available information, assistance, and authority to enable Seller (or its supplier) to assume such defense. Seller (or its supplier) shall diligently defend and prosecute all such patent infringement litigation and shall keep Purchaser fully informed of all developments in the defense or adjustments of any such claim or action. If a final injunction or judgment in any patent infringement action is rendered restraining Purchaser’s use of the Equipment, or of any component thereof, Seller shall, at its option and expense, either (i) procure for Purchaser the right to use the Equipment, or (ii) replace or modify the infringing component so that it no longer infringes, or (iii) repurchase the Equipment upon its return to Seller, less reasonable depreciation of 2% per month from date of installation, for use, damage, or obsolescence. Seller shall have no liability whatsoever to Purchaser if any such patent infringement or claim thereof is based upon or arises from (i) the use of any Equipment in combination with an apparatus or device not manufactured or supplied by Seller and such combination cause the infringement, (ii) the use of any Equipment in a manner for which it was neither designed nor contemplated, or (iii) any modification of any Equipment by Purchaser, or by Seller at Purchaser’s request, or by any third party, which causes the Equipment to become infringing.

  • INTELLECTUAL PROPERTY RIGHTS INDEMNITY (a) Customer shall promptly notify Signify of any third party claim alleging that any of the Products and/or Services supplied to Customer by Signify infringes any third party IPR. Upon such notice, Signify may at its own option and at its own expense either: (i) procure for Customer the right to continue using such Product and/or Services; or (ii) provide a replacement non-infringing product for such Product of equivalent functionality; or (iii) modify such Product such that it is no longer infringing; or (iv) remedy such Service; or (v) make an appropriate refund or credit of monies paid by Customer for that Product and/or Services.

Time is Money Join Law Insider Premium to draft better contracts faster.